LIGHT4LUNGS: Inhalable Aerosol Light Source for Controlling Drug-Resistant

Light4Lungs addresses the problem of antimicrobial resistance in the treatment of chronic lung infections, the leading cause of morbidity and mortality in patients with diseases such as cystic fibrosis and hospital-acquired lung infections. The project aims to develop an alternative therapeutic scheme for the treatment of these infections: a novel inhalable photodynamic therapy whereby antibiotics are replaced by inhalable light sources that will excite bacterial endogenous photosensitizers, eliminating the pathogenic bacteria by the photodynamic effect irrespective of their multidrug resistance profile.